Effects of the Mediterranean Diet on Stroke and Cognitive Decline in Patients with CADASIL and Cerebral Amyloid Angiopathy
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-09-01
86
Participants Needed
1
Research Sites
121 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of the Mediterranean Diet on patients with CADASIL and Cerebral Amyloid Angiopathy CAA, focusing on stroke incidence and cognitive decline. The study has two phases Phase 1 is observational, assessing patients nutritional status, dietary habits, and their adherence to the Mediterranean Diet. It also examines links between diet adherence and stroke severity or cognitive deficits.
Phase 2 is an interventional phase where participants follow either a Mediterranean Diet enriched with extra virgin olive oil, a Mediterranean Diet enriched with walnuts, or a low-fat control diet. The study evaluates how these diets influence stroke occurrence and cognitive changes over time.
Participants will undergo assessments of nutritional status, body composition, basal metabolism, and energy expenditure at baseline and throughout the study, which lasts up to 12 months. Researchers will monitor stroke incidence and cognitive decline, as well as adherence to the Mediterranean Diet at regular intervals to understand the impact of diet on these health outcomes.
CONDITIONS
Brief Title
Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy.
Research Team
A
Anna Bersano, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Lead Sponsor
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
Adults aged 18 years or older
Diagnosis of CADASIL confirmed by NOTCH3 gene mutation
Diagnosis of possible or probable Cerebral Amyloid Angiopathy according to Boston 2.0 criteria
Provide informed consent for anonymous use of demographic, clinical, and nutritional data
You will not qualify if you...
None specified
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Observational Phase
Duration - Up to 12 months
Participants' nutritional status, dietary habits, and adherence to the Mediterranean Diet are assessed. Researchers collect data on body composition, metabolism, stroke incidence, and cognitive function.
Assessments at baseline, 6 months, and 12 months
Intervention Phase
Duration - Up to 12 months
Participants follow one of the study diets: Mediterranean Diet enriched with extra virgin olive oil, Mediterranean Diet enriched with walnuts, or a low-fat control diet. Effects on stroke incidence and cognitive decline are evaluated.
Regular dietary monitoring and assessments
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Phase 2 Study of AMDX-2011P Intravenous Injection as a Retinal Tracer for Adults With Cerebral Amyloid Angiopathy
Evaluating the STRATIF-AI Digital Twin Platform for Secondary Prevention in Stroke, Moyamoya Disease, and Cerebral Amyloid Angiopathy A Randomized Controlled Proof-of-Concept Study
Study of Colchicine to Prevent Recurrence of Brain Bleeding in Patients with Cerebral Amyloid Angiopathy
A Phase II Randomized Trial Comparing Colchicine and Placebo Over One Year
Effects of the Mediterranean Diet on Stroke and Cognitive Decline in Patients with CADASIL and Cerebral Amyloid Angiopathy
Evaluating Jiedu Huayu Oral Prescription for Treating Intracranial Hemorrhage Linked to Cerebral Amyloid Angiopathy A Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
Prospective Study on Outcomes of Cerebral Small Vessel Disease Types and Symptoms
Italian Multicenter Study on Cerebral Amyloid Angiopathy Identifying Biomarkers and Understanding Disease Progression in Patients Aged 55 and Older
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Mediterranean diet: The role of long-chain ω-3 fatty acids in fish; polyphenols in fruits, vegetables, cereals, coffee, tea, cacao and wine; probiotics and vitamins in prevention of stroke, age-related cognitive decline, and Alzheimer disease.
High-Fat-Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders.
Mediterranean Diet in patients with acute ischemic stroke: Relationships between Mediterranean Diet score, diagnostic subtype, and stroke severity index.